It is not unusual in this business for Directors to consider shares being issued to them free of charge as a God given right. Director buying is not that prevalent due to the inherent flaws in the system.
On a valuation basis it is not out of the ordinary that an explorer be valued at between $100-$150 per resource ounce. RRL is currently being valued as an exploration play- totally ridiculous.
- Forums
- ASX - By Stock
- RRL
- Ann: Chairman's Address to Shareholders
RRL
regis resources limited
Add to My Watchlist
0.89%
!
$4.45

Ann: Chairman's Address to Shareholders, page-74
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$4.45 |
Change
-0.040(0.89%) |
Mkt cap ! $3.361B |
Open | High | Low | Value | Volume |
$4.47 | $4.53 | $4.45 | $6.320M | 1.407M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
26 | 24222 | $4.45 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$4.46 | 16416 | 29 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
60 | 28309 | 4.470 |
41 | 61950 | 4.460 |
24 | 51179 | 4.450 |
19 | 48786 | 4.440 |
14 | 144456 | 4.430 |
Price($) | Vol. | No. |
---|---|---|
4.480 | 32716 | 58 |
4.490 | 36887 | 35 |
4.500 | 55181 | 22 |
4.510 | 62480 | 16 |
4.520 | 54648 | 15 |
Last trade - 13.45pm 27/06/2025 (20 minute delay) ? |
Featured News
RRL (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online